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Secondary Diabetes Mellitus (DM) has been associated in
about 1-14% of patients with hematologic malignancy
treated with L-asparaginase. An 11-year old Filipino
female, diagnosed with Acute Lymphoblastic Leukemia,
developed hyperglycemia associated with polyuria and
polydipsia while on-going induction chemotherapy. There
was no family history of diabetes mellitus. Chemotherapy
drugs included L-Asparaginase, Prednisone, Vincristine
and intrathecal methotrexate using the LIC protocol.
Among these agents, Prednisone and L-Asparaginase are
known to cause hyperglycemia. Given the risk, the patient
was monitored by checking for glucosuria at least once a
week. The L-asparaginase was started on Day 8 of
chemotherapy after one week of Prednisone given at
60mg/kg/m2. No glucosuria was noted prior to the start,
as well as during the first week of chemotherapy. On Day
16 of chemotherapy, after 4 doses of L-Asparaginase at
6000u/m2 3x a week, she developed epigastric pain, vomit-
ing, polyuria, excessive thirst, hyperglycemia and gluco-
suria (+4). Arterial blood gas was normal and negative for
urine ketones. Serum amylase and lipase were likewise
normal. The Random blood sugar was 680 mg/dL
(37.4mmol/L). Upon repeat the next day, it was 619 mg/dl
and HbA1c at 7.4%. Regular insulin started at a dose of
0.8unit/kg/day given every six hours which was later
increased to 1unit/kg/day. The patient was maintained on
pre-mix Insulin (70% isophane/ 30% regular) at 1.2 unit
per/kg/day with good control of blood sugar between 100-
200mg/dl. L-Asparaginase was completed for 9 doses. The
patient required tapering doses of insulin therapy for one
month after the last dose of L-Asparaginase. After discon-
tinuation of insulin, blood monitoring for two more weeks
showed no recurrence of hyperglycemia and the associated
symptoms.
Inhibition of insulin and insulin receptor synthesis, lead-
ing to a combined insulin deficiency and resistance
syndrome, is the supposed mechanism of the L-asparagi-
nase effect. The temporal relationship of the appearance
and resolution of hyperglycemia with the L-Asparaginase
administration and discontinuation respectively, is the
strong basis for attributing the transient DM to the said
agent rather than to steroids. However, the risk and
severity of DM increases when L-asparaginase and steroids
are used concomitantly. Close monitoring of the blood
sugar levels of such patients is emphasized.
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